<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132836">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01944878</url>
  </required_header>
  <id_info>
    <org_study_id>BCS-1</org_study_id>
    <nct_id>NCT01944878</nct_id>
  </id_info>
  <brief_title>The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient</brief_title>
  <official_title>Retrospective Observational Study of Impact of Portal Hypertension for the Peptic Ulcer in Liver Cirrhosis and Chronic Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chuncheon Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chuncheon Sacred Heart Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the role of portal hypertension of peptic ulcer disease
      in liver cirrhosis and chronic hepatitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective case-control study

        -  Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG)
           and esophagogastroduodenoscopy (EGD) cases who had liver cirrhosis (LC) or chronic
           hepatitis in a single tertiary hospital (Chuncheon Sacred Heart hospital, Korea) within
           2008~2012.

        -  Portal hypertension is assessed using HVPG measurement via transjugular approach.

        -  Peptic ulcer is evaluated through EGD within 3 months of HVPG measurement

        -  The association of Peptic ulcer with LC, chronic hepatitis and total population (LC or
           chronic hepatitis) will be assessed by univariate and multivariate analysis

        -  There is no specific time frame, because this study is retrospective observational
           study, however EGD data is enrolled if it was done within 3 month from HVPG
           measurement.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>The association of HVPG and PUD</measure>
    <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease will be assessed statistically (NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The student T-test or Mann-Whitney test will be used to evaluate the association between PUD or not and HVPG degree, by SPSS software.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference of impact of portal hypertension for PUD between LC and chronic hepatitis</measure>
    <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The difference of impact of HVPG reflecting portal hypertension for peptic ulcer disease between liver cirrhosis and chronic hepatitis will be assessed, stastistically. (NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Student's T test or Mann whitney test will be used to evaluate the difference of HVPG degree between LC-PUD and Chronic hepatitis-PUD.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The risk factor of PUD in LC and chronic hepatitis</measure>
    <time_frame>Retrospective case-control study (from 2009 to 2012, up to 3 years)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The risk factor of PUD in liver cirrhosis and chronic hepatitis will be assessed, statistically. (NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). Logistic regression analysis will be used to detect the risk factor of LC-PUD and chronic hepatitis-PUD.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Chronic Liver Disease</condition>
  <arm_group>
    <arm_group_label>Patients with chronic hepatitis</arm_group_label>
    <description>Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with liver cirrhosis</arm_group_label>
    <description>Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG)
        and esophagogastroduodenoscopy (EGD) cases who had LC or chronic hepatitis in single
        tertiary hospital of Korea.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients who underwent hepatic vein pressure gradient (HVPG) measurement and
             esophagogastroduodenoscopy (EGD) and also had LC or chronic hepatitis

        Exclusion Criteria:

          -  The patients who have missing or incomplete HVPG or EGD data

          -  The patients who underwent gastrectomy

          -  The patients who have systemic malignancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Seok Bang, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine, Hallym University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gwang Ho Baik, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Internal Medicine, Hallym University College of Internal Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chuncheon Sacred Heart hospital</name>
      <address>
        <city>Chuncheon</city>
        <state>Gangwon-do</state>
        <zip>200-704</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, Cavalli G, Barbara L. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995 Jun;22(6):633-41.</citation>
    <PMID>7560857</PMID>
  </reference>
  <reference>
    <citation>Vergara M, Calvet X, Roqu√© M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. 2002 Jul;14(7):717-22.</citation>
    <PMID>12169979</PMID>
  </reference>
  <reference>
    <citation>Kamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, Pramoolsinsap C. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1459-65.</citation>
    <PMID>15948813</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>September 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chuncheon Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Chang Seok Bang</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Peptic ulcer</keyword>
  <keyword>Liver cirrhosis</keyword>
  <keyword>Portal hypertension</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
